Clinical trial
Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus…
NCT00105157 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00105157 |
|---|---|
| Title | Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED) |
| Official title | Multicenter Study to Evaluate the Safety and Efficacy of MK0518 in Combination With An Optimized Background Therapy (OBT), Versus OBT Alone, in HIV-Infected Patients With Documented Resistance |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Acquired Immunodeficiency Syndrome |
| Intervention type | Drug |
| Interventions | Comparator: MK0518, MK0518, Placebo |
| Enrollment | 179 |
| Start date | Mar 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Jul 1, 2009 |
| First posted | Mar 9, 2005 |
| Last update posted | Dec 4, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: